Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Market penetration
Increasing a company's market share in a new or existing market using such tactics as heavy promotion and pricing strategies. These strategies may include comprehensive advertising, decreased prices, or mass discounts.
Market penetration also refers to the measure of a product's sales figure comparable to the total sales figure of all rival products, denoted as a percentage.
An equation ruling to the above is: Sales volume of 1 unit x 100 ÷ Total sales volume of all rival products.
See also:
Marketing strategy
Market penetration strategy
Market penetration pricing
Related terms
Convenience sampling, Demographics, Marketing metrics, Brand revitalisation, Market entry barrier, Multi-brand strategy, Market niche, Direct-to-consumer (DTC), Conjoint analysis, Monopoly, Marketing plan, Neuromarketing, Segmentation, Diversification, Penetrated market,
COVID-19 Updates and Daily News
Featured jobs
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
- Recognising HIV Vaccine Awareness Day
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Scientists discover new approach to treat brain tumours
- UICC launches global ATOM Coalition to increase access to essential cancer medicines
- Almirall and Evotec team up in multi-target dermatology alliance
- When is an agency not an agency?
- Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- Positive CHMP opinion issued for PTC Therapeutics’ Upstaza
- Live Webinar: The Future of MedTech: Streamlined Clinical Data Collection & Management
- Medscape: Connect to the conversation
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- J&J appoints Thibaut Mongon as CEO designate of New Consumer Health Company
- MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
